Passage Bio, Inc. (PASG) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Passage Bio, Inc. (PASG) Earnings Overview
As of July 7, 2026, Passage Bio, Inc. (PASG) reported trailing twelve-month net income of -$38M, reflecting +33.1% year-over-year growth. The company earned $-11.75 per diluted share over the past four quarters.
Looking at the long-term picture, PASG's historical earnings data spans multiple years. The company achieved its highest annual net income of -$13M in fiscal 2018.
Passage Bio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KRYS ($225M net income, 52.6% margin), RCKT (-$209M net income), RARE (-$609M net income, -85.4% margin), PASG has comparable earnings metrics. Compare PASG vs KRYS →
PASG Earnings vs Peers
Earnings metrics vs comparable public companies
PASG Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$46M | +29.7% | -$43M | $-14.35 | - | - |
| 2024 | -$65M | +36.5% | -$70M | $-21.44 | - | - |
| 2023 | -$102M | +25.0% | -$100M | $-37.29 | - | - |
| 2022 | -$136M | +26.6% | -$138M | $-50.00 | - | - |
| 2021 | -$185M | -65.2% | -$186M | $-69.51 | - | - |
| 2020 | -$112M | -145.9% | -$113M | $-57.80 | - | - |
| 2019 | -$46M | -257.4% | -$37M | $-45.60 | - | - |
| 2018 | -$13M | - | -$13M | $-10.60 | - | - |
Download Data
Export PASG earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PASG — Frequently Asked Questions
Quick answers to the most common questions about buying PASG stock.
What is PASG earnings per share (EPS)?
PASG trailing twelve-month (TTM) diluted EPS is $-11.75, reflecting +33.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is Passage Bio, Inc.'s net income?
Passage Bio, Inc. (PASG) trailing twelve-month net income is $-38M as of 2025. Earnings grew +33.1% year-over-year.
Is PASG profitable?
PASG is not currently profitable on a TTM basis, reporting a net loss of $-38M. Net margin is N/A. Investors should monitor for a return to profitability.
What is PASG's earnings growth rate?
PASG compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are PASG's profit margins?
Passage Bio, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -113.8%.
Is PASG growing earnings?
Yes, PASG earnings are accelerating — EPS growth of +33.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-38M. Earnings momentum is strengthening.
What was PASG's best earnings year?
Passage Bio, Inc.'s highest annual net income on record is $-13M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were PASG's earnings last quarter?
PASG's most recent reported quarter was Q1 2026. Net income was $-8M with diluted EPS of $-2.36. For a full breakdown of all quarters, see the quarterly earnings table on this page.